The Biotech Project
Scott Resnik and John Walsh, MD
Add to My Podcasts
Episodes
About
Reviews
Promote
Show notes
Join us as we talk with CEO of VistaGen Therapeutics, Shawn Singh. Shawn discusses the current state of depression and anxiety therapeutics and how VistaGen hopes to change the way this unmet need is addressed with a novel new approach.
Listen Instead
Switch to Audio
Refresh video
Previous
Episode 11- Getting to know your host, Dr John Walsh
Next
Episode 13 - Talking with Kristen Mahoney about transitioning from the nursing field to the Sales role
← See all 18 episodes of The Biotech Project